🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to the Clinical Information Network team on winning the Vice-Chancellor’s Research Engagement Award in recognition of their work, "Engaging stakeholders to build a Kenyan learning health system"🏆! Click the link below to read more! 🔗: shorturl.at/8bkI7

Call for Applications📢! Apply to Vaccinology in Africa Course 2025! Click the link below to apply! 🔗: English - shorturl.at/JAsZa French - shorturl.at/Pw5qv 📍: Institut Pasteur de Dakar, Sénégal Deadline: May 30th, 2025, at 5:00 PM EAT

Congratulations to Prof. Abdirahman Abdi, Senior Research Scientist, KEMRI-Wellcome Trust, on being awarded an Associate Professorship at University of Oxford in recognition of his outstanding research achievements and contribution to teaching and the general work of the Nuffield Department of Medicine !

It was a real privilege to host Neil Wigan , the British High Commissioner to Kenya, at KEMRI-Wellcome today. His strong support for our work and the UK’s continued commitment to research partnerships in Kenya is deeply appreciated.

Yesterday I visited KEMRI-Wellcome Trust which has done ground breaking medical research in Kilifi since 1989. I met world class Kenyan scientists making life saving discoveries. A perfect example of 🇬🇧 🇰🇪 collaboration.

Fantastic UK - Kenya collaboration!

#ResearchHighlight from Marta Maia KEMRI-Wellcome Trust Phenotypic and genotypic insecticide #resistance profiles of main #malaria vectors in Kwale county, coastal Kenya Read more 👉 ndm.ac/tropmed.res-hi Full publication 👉 malariajournal.biomedcentral.com/articles/10.11…

📢Our 2024 Annual Report is here! 2024 was an exciting year of progress and growth for the Programme. Themed “Advancing global health innovation and nurturing research leadership,” the report highlights our shared success. Please read more below. Inside: 🔬 Cutting-edge

Very proud of my colleagues KEMRI-Wellcome who continue to drive change through impactful health research and capacity building

STAGGERING: This new study of 133 countries is the first to estimate the impact of all USAID’s work. In 2 decades, it saved *92M* lives. Current cuts, if not reversed, are forecast to cost *14M* lives thru 2030. thelancet.com/journals/lance…

The KWTRP School Leavers Attachment Scheme 2025 cohort showcased their learning and experience gained through the three-month attachment and mentorship program. The initiative conducted in partnership with the School Engagement Programme(SEP), Stanford Scholars and Science Mentorship Institute

HOT OFF THE PRESS!Economic evaluation of caregiver interventions for children with developmental disabilities: A scoping review journals.plos.org/globalpubliche…

Celebrating Kelvin Mokaya's achievement in defending his Viva! Here’s a look at his impactful #research: He investigated the epidemiology and biological mechanisms of severe anaemia and bacterial infections in Kenyan children, work that will shape better diagnosis and care.

Is there anything more annoying than buzzing mosquitoes at night? 🦟Yes! Mosquitoes and beg bugs! Our new study shows that ivermectin at clinically relevant blood levels not only kills malaria mosquitoes, but also bed bugs 💀 parasitesandvectors.biomedcentral.com/articles/10.11…

📣How can Social Health Insurance better support #UHC in LMICs? Join KEMRI-Wellcome at #IHEA2025 for a powerhouse panel unpacking SHI design, performance & lessons from LMICs🌍 With Joe Kutzin Kara Hanson Edwine Barasa John E. Ataguba Dr. Ama Fenny Beryl Maritim Dr. Mercy Mwangangi

One more day to go if you registered to join this International Health Economics Association (IHEA) pre-congress session. See you there!

Thrilled to share groundbreaking research from my colleagues @kemri_wellcome - "Ivermectin to Control Malaria - A Cluster-Randomized Trial." Key Findings: - Mass administration of ivermectin (400 μg/kg) reduced malaria incidence by 26% compared to albendazole in children aged

A groundbreaking study backed by the Kenya Medical Research Institute (KEMRI) has revealed that ivermectin, when administered through mass drug administration (MDA), can reduce malaria infections by 26 per cent. Follow thestarhealth for more health updates